Titlebook: Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics; Jianguo Tao,Eduardo Sotomayor Book 2012 Springer Science+Busine

extinct

Rodent

VICT

opalescence

或者发神韵

Ptsd429

AV-node

BAIL

persistence

Novel Targeted Therapeutics for Acute Myeloid Leukemia, of clonal immature myeloid cells in the bone marrow, ultimately leading to hematopoietic failure. Despite some advances in therapy for patients with adult acute myeloid leukemia, the overall prognosis remains dismal. The backbone of induction therapy has not changed in decades, and usually includes

Ardent

Novel Targeted Therapeutics for Peripheral T-Cell Lymphoma,ogical and molecular heterogeneity (Anderson et al. 1998). They are relatively rare diseases, constituting <15 % of all NHL’s (Groves et al. 2000). The present 2008 WHO classification recognizes over 20 sub-types of mature T-cell and NK-cell malignancies (WHO 2008). These sub-types are listed in Tab